WPRIM Management System> DCMS> China Oncology> 2006> 0> 07

Volume: 0 Issue: 07

1. Advances in research of MAGE-A3 Page:—
2. Expression of cyclooxygenase-2 and its clinicopathologic and prognostic significance in endometrial cancer Page:—
3. Diagnosis,treatments and prognosis of local recurrence of breast cancer after conservative therapy Page:—
4. Progression and study of the catalytic subunit of human telomerase(hTERT) in tumor therapy Page:—
5. Detection of bone marrow involvement using flow cytometry in B cell lymphoma Page:—
6. The expressions of COX-2 and VEGF-C in stage Ⅱ and Ⅲ rectal cancer and its association with angiogenesis and prognoses Page:—
7. Study on the expression of PTEN and P53 in human primary gallbladder carcinoma(HGC) Page:—
8. The study on the expression of HIF-1? and its association with the expression of HER-2 and survivin in breast carcinoma Page:—
9. The Effects of rhG-CSF on morphology,phenotype and function of neutrophil in patients with malignant lymphoma after the treatment of chemotherapy Page:—
10. The impact of DOC-2 expression on the tumorigenesis of human ovarian cancer cell line(HO-8910) Page:—
11. Comparison of intensity-modulated and three-dimensional conformal techniques for radiotherapy of esophageal carcinoma Page:—
12. Modified three-weeks' docetaxel/cisplatin as first line chemotherapy for advanced non-small cell lung cancer Page:—
13. Influence of MRI on the staging system of 78 patients with nasopharyngeal carcinoma (NPC) Page:—
14. Prognostic factor analysis of 603 cases with gastric cancer undergoing radical resection Page:—
15. Primary renal lymphoma of mucosa-associated lymphoid tissue: report of 2 cases and review of literatures Page:—
16. Expression of death-associated protein kinase 1 in papillary thyroid carcinoma Page:—
17. Effect on radiation-induced apoptosis of HeLa cells by inhibiting expression of NF-?B Page:—
18. The effect of TFPI-2 gene on apoptosis of pancreatic cancer cell Page:—
19. Advances on immunohistochemistry and genetical detection in diagnosis of synovial sarcoma Page:—
20. The impact of radiotherapy on breast reconstruction Page:—
21. Advances in the study of carotid injury after radiotherapy in head and neck tumors Page:—
22. Clinical characteristics,treatment and prognosis of 11 cases with extraovarian peritoneal serous papillary carcinoma Page:—
23. Clinical observation on irinotecan as second-line treatment of patients with advanced colorectal carcinoma Page:—
24. Clinical effi ciency of pemetrexed in the treatment of advanced retreated non-small cell lung cancer Page:—
25. Randomized study of docetaxcel plus cisplatin versus gecitabine plus cisplatin in treatment of advanced non-small cell lung caner Page:—
26. The effect of preoperative chemotherapy in stage Ⅰ_(b2) cervical cancer Page:—
27. The clinicopathological analysis of gastrointestinal stromal tumors with hepatic metastasis and a review of literature Page:—
28. Preliminary isolation and identifi cation of cancer stem-like cells in colon cancer cell line SW480 Page:—
29. The effect of carboplatin, on fractional dissection form, combined with X-ray on the immune function of the Lewis lung cancer Page:—
30. Association of BRCA1-related DNA repair genetic variations and high incidence of metastasis in triple-negative breast cancer Page:—
31. Clinical progress of the research on circulating tumor cells in colorectal cancer Page:—
32. The investigation of the clinical characteristics and surgery on Hashimoto’s disease coexistent with thyroid neoplasm Page:—
33. Expression and clinical significance of vascular endothelial growth factor and epidermal growth factor in non-small cell lung cancer Page:—
34. hMLH1 promoter hypermethylation correlates with platinum-resistance in non-small cell lung cancer cells Page:—
35. Newly interrupted techniques and procedures to prevent gastric cancer cells dissemination in the radical resection of gastric cancer Page:—
36. Elemene emulsion combined with NP chemotherapy in the treatment of advanced NSCLC patients Page:—
37. Oophorectomy combined with exemestane treating advanced refractory breast cancer Page:—